MerckInc Insider Trades

MRK

Track insider trading activity from Merck & Co., Inc. (MRK) executives and directors, a global pharmaceutical leader headquartered in Rahway, New Jersey. The company, known as MSD outside the U.S. and Canada, focuses on developing innovative medicines, vaccines, and animal health products, with key revenue streams from oncology treatments like Keytruda and vaccines such as Gardasil. Key figures at the company include Chairman, President, and CEO Robert M. Davis, along with executives such as CFO Caroline Litchfield. While insider ownership of Merck stock is relatively low, there is a general pattern of both buying and selling activity among the company's insiders over time.

Trades Last 12 Months

MRK Price

All Insider Trades for MerckInc

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Thulin Inge G Director
Holding Value $3.15M 27,469 shares
Last Trade
May 29, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$220k 1,853 shares
$118.72
$114.80
Holding Value $2.04M 17,749 shares
Last Trade
May 29, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$220k 1,853 shares
$118.72
$114.80
Craig Pamela J. Director
Holding Value $4.01M 34,944 shares
Last Trade
May 29, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$220k 1,853 shares
$118.72
$114.80
Holding Value $619k 5,392 shares
Last Trade
May 29, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$220k 1,853 shares
$118.72
$114.80
Holding Value $2.44M 21,228 shares
Last Trade
May 29, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$220k 1,853 shares
$118.72
$114.80
Coe Mary Ellen Director
Holding Value $3.65M 31,765 shares
Last Trade
May 29, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$220k 1,853 shares
$118.72
$114.80
Warden Kathy J Director
Holding Value $2.05M 17,890 shares
Last Trade
May 29, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$220k 1,853 shares
$118.72
$114.80
Glocer Thomas H Director
Holding Value $12.7M 110,911 shares
Last Trade
May 29, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$220k 1,853 shares
$118.72
$114.80
Russo Patricia F Director
Holding Value $7.16M 62,390 shares
Last Trade
May 29, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$220k 1,853 shares
$118.72
$114.80
Mayo Stephen Director
Holding Value $1.7M 14,824 shares
Last Trade
May 29, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$220k 1,853 shares
$118.72
$114.80
Holding Value $1.32M 11,518 shares
Last Trade
May 29, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$220k 1,853 shares
$118.72
$114.80
Rothman Paul Director
Holding Value $4.01M 34,944 shares
Last Trade
May 29, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$220k 1,853 shares
$118.72
$114.80
Foard Brian Evp, Specialty, Pharma, & ID
Holding Value $4.06M 35,351 shares
Last Trade
May 05, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.71M 77,000 shares
$113.16
$114.80
Holding Value $5.35M 46,566 shares
Last Trade
May 05, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.07M 62,474 shares
$113.16
$114.80
Oosthuizen Johannes Jacobus Evp, Oncology & Int?l
Holding Value $3.56M 31,044 shares
Last Trade
May 05, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.71M 41,649 shares
$113.16
$114.80
Davis Robert M Chairman, CEO & President
Holding Value $16M 139,697 shares
Last Trade
May 05, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$21.2M 187,421 shares
$113.16
$114.80
Guindo Chirfi Evp, Access, Policy & Comms
Holding Value $2.23M 19,402 shares
Last Trade
May 05, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.95M 26,030 shares
$113.16
$114.80
De Luca Richard R. Evp&pres, Merck Animal Heallth
Holding Value $1.37M 11,931 shares
Last Trade
May 05, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.35M 11,931 shares
$113.16
$114.80
Larson Betty D Evp, Chief HR Officer
Holding Value $2.67M 23,283 shares
Last Trade
May 05, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.53M 31,237 shares
$113.16
$114.80
Li Dean Y Executive VP & President, MRL
Holding Value $6.68M 58,207 shares
Last Trade
May 05, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.84M 78,092 shares
$113.16
$114.80

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up